Mylan Pharmaceuticals Inc. et al. vs Genentech, Inc.

Notice of Refund

MYLAN PHARMACEUTICALS INC.'S REQUEST FOR REFUND OF POST-INSTITUTION FEE AND EXCESS CLAIM FEES FOR INTER PARTES REVIEW OF U.S. PATENT NO. 6,407,213

Termination Decision Document

Parties e-mail 3-7-17

Joint Motion to Terminate Proceeding Pursuant to 35 U.S.C. 317(a)

Confidential Settlement Agreement

Joint Request that Settlement Agreement be Treated as Business Confidential Information

Petitioners Updated Exhibit List

EXPUNGED

Parties email dated Feb. 24. 2017

Order Conduct of Proceeding

Mylan Pharmaceuticals Inc.'s Mandatory Notice

MYLAN PHARMACEUTICALS INC.¿¿¿S POWER OF ATTORNEY

Order - Patent Owner's Motions for Pro Hac Vice Admission of Robert J. Gunther, Jr. and Daralyn J. Durie - 37 CFR 42.10

Decision - Patent Owner's Motion to Seal - 37 CFR 42.14

IPR2016-01693 Gunther Pro Hac Vice Motion

Exhibit 2032 Gunther Pro Hac Vice Declaration IPR2016-01693

IPR2016-01693 Durie Pro Hac Vice Motion

Exhibit 2033 Durie Pro Hac Vice Declaration IPR2016-01693

Exhibit 2004 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 11643 Paul Carter

Exhibit 2009 PARTIES AND BOARD ONLY Excerpts from Genentech Laboratory Notebook 11568 Monique Carver

Exhibit 2010 PARTIES AND BOARD ONLY Genentech, Memorandum from Paul Carter to Leonard Presta and Dennis Henner

Patent Owner's Preliminary Response - PARTIES AND BOARD ONLY

Genentech, Inc. Laboratory Notebook No. 10098 (Leonard Presta) PROTECTIVE ORDER MATERIAL

Exhibit 2002 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 10823 Leonard Presta

Exhibit 2003 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 11268 Paul Carter

Exhibit 2005 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 10840 John Brady

Exhibit 2007 PARTIES AND BOARD ONLY Excerpts from Genentech Laboratory Notebook 11008 Ann Rowland

Exhibit 2008 PARTIES AND BOARD ONLY Excerpts from Genentech Laboratory Notebook 11297 Tim Hotaling

Exhibit 2011 PARTIES AND BOARD ONLY Genentech, Memorandum from Paul Carter to Leonard Presta

Exhibit 2013 PARTIES AND BOARD ONLY Genentech, Synthetic DNA Requests

Exhibit 2012 PARTIES AND BOARD ONLY Genentech, Synthetic DNA Requests

Exhibit 2015 PARTIES AND BOARD ONLY Genentech Memorandum re RCC Minutes and Recommendations

Exhibit 2019 Carter Humanization of the Anti p185 Antibody for Human Cancer Therapy

Exhibit 2021 Bruggerman The Immunogenicity of Chimeric Antibodies

Exhibit 2022 Kalsi Structure function Analysis

Exhibit 2023 PUBLIC Gorman Reshaping a Therapeutic

Exhibit 2020 PUBLIC Presta Humanization of an Anti Vascular Endothelial Growth Factor

Exhibit 2024 PUBLIC Isaacs Humanised Monoclonal Antibody Therapy

Exhibit 2026 PUBLIC Tramantano Framework Residue

Exhibit 2028 Excerpt from Roche Finance Report 2015

Exhibit 2027 SHEPARD Herceptin in Therapeutic Antibodies

Exhibit 2031 Modified Default Standing Protective Order

Exhibit 2006 PARTIES AND BOARD ONLY Genentech Laboratory Notebook 11162 John Brady

Exhibit 2016 Declaration of Irene Loeffler

Exhibit 2025 Kabat Sequences of Proteins of Immunological Interest 1987

Exhibit 2018 PARTIES AND BOARD ONLY Declaration of John Ridgway Brady

Exhibit 2029 Declaration of Dr. Leonard G. Presta

Patent Owner's Preliminary Response

Exhibit 2017 Modified Default Standing Protective Order ¿¿¿ Redline

Exhibit 2014 Genentech Protein Engineering of 4D5 Status Report

Exhibit 2018 Declaration of John Ridgway Brady

Exhibit 2029 PARTIES AND BOARD ONLY Declaration of Dr Leonard G Presta

Exhibit 2030 PARTIES AND BOARD ONLY Declaration of Dr Paul J Carter

Exhibit 2030 Declaration of Dr Paul J Carter

Patent Owners Motion to Seal

EXPUNGED

Notice of Accepting Corrected Petition

Patent Owner's Mandatory Notices

Patent Owners Power of Attorney

Certification of Word Count of Petition Pursuant to 37 C.F.R. 42.24(d)

Petitioner's Notice of and Submission of Corrected Exhibit No. 1117

Boulianne 1984

Notice of Accord Filing Date - Defective Petition

U.S. Patent No. 6,407,213,

File History for U.S. Patent No. 6,407,213 Part II

Ball E.D., et al. Clin Cancer Res 1:965-972 (September 1995)

Bashey A., Ball E.D., et al. Blood 113(7):1581-1588 (2009)

Armand P., Ball E.D., J. Clin. Oncol. 31(33):4199-4206 (November 20, 2013)

Ball E.D., et al. J. Hematotherapy 1:85-94 (1992)

Ball E.D., Blood (ASH Annual Meeting Abstracts) 116: Abstract 3286 (2010)

Prabakaran, S. Science, 349(6246):389 (July 24, 2015)

Marks, L. The story of Cesar Milstein (last accessed September 08, 2015)

OMTSG N. Engl. J. Med. 313(6):337-342 (August 8, 1985)

Protein Data Bank ¿¿¿ Chronology (accessed August 29, 2016)

Morrison et al.,Pro. Nat¿¿¿l Acad. Sci. 81:6851-6855 (November 1984).

Jones et al. Nature 321:522-525 (1986)

Kirkman et al.,Transplant. Proc. 21:1766-1768 (1989)

Hakimi et al. J. Immunol. 147:1352-1359 (August 15, 1991)

File History for U.S. Patent No. 6,407,213 Part I

BALL, ED et al. J. Immunol. 128(3):1476-81 (March 1982)

Ball, E.D., et al. J. Nat¿¿¿l Cancer Inst. 72(3):593-598 (March 1984)

Magnani et al., Arch. Biochem. Biophys. 233(2):501-506 (September 1984)

Memoli, et al Cancer Res. 48:7319-7322 ( December 15, 1988)

Ball E.D., et al. Blood 62(6):1203-1210 (December 1983)

Chen J, Zhou J.H., Ball E.D. Clin. Can. Res. 1:1319-1325(November 1995)

Balaian, L., et al., Leukemia Res. 25:1115-1125 (2001)

Chen J., Ball, E.D., et al. Clin. Can. Res. 1:425-434 (April 1995)

Chen J., Ball, E.D., et al. Peptides 1994. 819-820(1995)

Zhou J.H., Ball E.D., et al. Peptides 1996, 935-936 (1998)

Ball, E.D., et al. Leukemia, 20:2093-2101 (2006)

Hudziak et al. Mol. Cell Biol. 9(3):1165-1172 (March 1989)

K¿¿hler and Milstein, Nature 256(5517):495-497 (August 7, 1975)

Cosimi et al., Transplantation 32:535-539 (1981)

Jaffers et al. Transplantation 41(5):572-578 (1986)

Sears et al. The Lancet 762-765 (April 3, 1982)

Sikora J. Clin. Pathol. 35:369-375 (1982)

Liu et al., Pro. Nat¿¿¿l Acad. Sci. 84:3439-3443 (May 1987).

Queen et al. Pro. Nat¿¿¿l Acad. Sci. 86:10029-10033 (1989)

Waldmann et al. Blood 72:1705-1716 (1988)

King C.R., et al. Science 229:974-976 (1985)

Coussens L., et al. Science 230:1132-1139 (December 6, 1985)

Fukushige S., et al. Mol. Cell. Biol. 6:955-958 (1986)

Kieber-Emmons et al. Intern. Rev. Immunol. 2:339-356 (1987)

Johnson and Wu, Methods in Molecular Biology 248:11-25 (December 2003)

Chothia & Lesk, J. Mol. Biol. 196:901-917 (1987)

Lind, et al. Immunoconj. Radiopharm. 4(4):811-818 (1991)

Mountain and Adair, Biotech. Genet. Eng. Rev. 10:1-142 (1992)

Verhoeyen, Milstein & Winter et al. Science 239:1534- 1536 (March 25, 1988)

Vincenti et al., N. Engl. J. Med. 338(3):161-165 (January 15, 1998)

SEER Stat Fact Sheets: Breast Cancer (last accessed September 08, 2015)

Harris, J.R., et al. N. Engl. J. Med. 327(5):319-328 (1992)

Semba K., et al. Pro. Nat¿¿¿l Acad. Sci. 82:6497-6501 (1985)

Slamon, D.J. et al. Science 235:177-182 (1987)

Kraus, M.H., et al. The EMBO Journal 6(3):605-610 (1987)

Hudziak, R. M., et al. Pro. Natl Acad. Sci. 84:7159-7163 (1987)

Hudziak, R. M., et al.Pro. Natl Acad. Sci. 84:7159-7163 (1987)

Chothia, C. et al. Nature 342(21):877-883 (December 1989).

Queen, Cary L. WO 1990/07861 (published July 26, 1990)

Tramontano, A. et al., J. Mol. Biol. 215:175-182 (1990)

Kabat, et al.(National Institutes of Health, Bethesda, Md.) (1987)

Wu and Kabat,J. Exp. Med. 132:211-250 (1970)

Milstein, et al. Proc. Royal Soc. London 211:393-412 (March 27, 1981)

Davies & Metzge Annu. Rev. Immunol. 1:87-117 (1983)

Amit et al. Science 233:747-53 (1986)

Lascombe et al. Pro. Natl Acad. Sci. 86:607-611 (January 1989)

Novotn¿¿ et al. J. Biol. Chem. 258(23):14433-14437 (December 10, 1983)

Chothia et al. J. Mol. Biol. 186:651-63 (1985)

Van Kroonenburgh & Pauwels, Nucl. Med. Commun. 9:919-30 (1988)

Tjandra et al. Immunol. Cell. Biol. 68:367-76 (1990)

Kurrle EP0403156.(1990)

Shearman, et al. J. Immunol. 147(12):4366-4373, (December 15, 1991)

Winter et al. EP0239400 Published September 30, 1987.

Accelrys Inc.(Last accessed October 16, 2015)

Chothia et al. Science New Series, 233(4765):755-758 (August 15, 1986)

Herron et al. Proteins 5:271-280 (1989)

File History for Patent Interference No. 105,744

Colman et al., Nature 326:358 (1987)

Bender et al., Rheumatol. Int. 27:269-74 (2007)

Brient, et. al., J Exp Med. 132:951-62 (1970)

Koprowski et al., Proc. Natl. Acad. Sci. U.S.A. 81:216 (1984)

Chanh et al., Proc. Natl. Acad. Sci. U.S.A. 84:3891 (1987)

Schroff et al., Cancer Res. 45:879 (1985)

Abdou et al., J. Clin. Invest. 67:1297 (1981)

Harris, L.J. et al. Nature 360:369-72 (1992)

Janeway, C.A. et al., (4th ed., Garland Science Publishing, NY, (1999)

Riechmann, et al. Nature 332:323-327 (March 24, 1988)

Tempest, et al. BioTechnology 9:266-271 (March 1991)

Dayringer et al., J. Mol. Graphics 4(2):82-87 (1986)

Loew, G. et al. Int. J. Quant. Chem. Quant. Biol. 15:55-66 (1988)

Bruccoleri et al. Nature 335(6):564-568 (1988)

Kabat et al., (National Institutes of Health, Bethesda, Md.) (1983).

Bernstein et al. J. Mol. Biol. 112:535-542 (1977)

Sheriff et al. Proc. Natl Acad. Sci. U.S.A. 84:8075 (1987)

Marquart et al. Immun. Today 3(6):160-166 (1982)

Saul et al. J. Biol. Chem. 253:585 (1978)

Navia et al. Proc. Natl. Acad. Sci. 76(8):4071-4074 (August 1979)

Satow et al. J. Mol. Biol. 190:593-604 (1986)

Padlan et al. Proc. Natl Acad. Sci. 86:5938-5942 (August 1989)

Kumar et al. Mol. Cell. Biol. 11(2):979-986 (February 1991)

Soomro et al. J. Clin. Pathol. 44:211-14 (1991)

Wilson & Goulding, Protein sequencing, 170-173 (3rd ed., 1986)

Edelman et al. Proc. Natl Acad. Sci 63:78-85 (1969)

Capra, et al. Proc. Natl Acad. Sci. 71:845-8 (1974)

Morin, Michael J. Oncogene 19:6574- 6583 (2000)

File History for U.S. Patent Application No. 07/715,272

US Patent No. 5,677,171

Sambrook et al., (2d ed., Cold Spring Harbor Laboratory Press) (1989)

Daugherty et al., Nucl. Acids Res. 19(9):2471-2476 (May 1991).

Padlan and Kabat, Meth. Enzymol. 203:3 (1991).

Tulip et al. Cold Spring Harbor Symp. Quant. Biol. 4:257 (1989)

Mian, I.S., J. Mol. Biol. 217:133-51 (1991)

Poljak et al. Proc. Natl Acad. Sci. U.S.A. 71:3440-4 (1974)

Padlan, E.A. Mol. Immunol. 28:489-98 (1991)

Padlan, Eduardo A., IBC International Conference (December 16-18, 1991)

Suh et al., Proteins 1:74 (1986)

U.S. Patent No. 5,889,157 (Issued March 30, 1999)

Furey et al. J. Mol. Biol. 167:661-92 (1983)

Segal et al. Proc. Natl Acad. Sci. U.S.A. 71:4298 (1974)

Jones, et al. Meth. Enzymol. 115:157-71 (1985)

History of Microsoft Excel 1978-2013 (accessed August 29, 2016)

U.S. Patent No. 4,891,762 (Issued January 2, 1990)

Potter, M. Physiol. Rev. 52:631-719 (1972)

Kabat and Wu, Ann. NY Acad. Sci. 190:382-93 (1971)

Davies et al. Ann. Rev. Biochem. 59;439-73 (1990).

Epp et al., Biochem. 14:4943 (1975)

Padlan et al. Cold Spring Harbor Symp. Quant. Biol. 41:627-37 (1977))

EXPUNGED

U.S. Patent No. 6,797,492 (Issued September 28, 2004)

U.S. Patent No. 5,792,852 (Issued August 11, 1998)

US Patent No. 5,795,965 (Issued August 18, 1998)

Co, M. et al. Proc. Natl Acad. Sci. U.S.A. 88:2869-73 (1991)

Wallick, S. et al. J. Exp. Med. 168:1099-109 (1988)

Petitioner Mylan Pharmaceuticals Inc.'s Power of Attorney

Kabat 1991

Exhibit 1003A Dr. Eduardo A. Padlan's CV

Exhibit 1003B - References Considered

Expert Declaration of Eduardo A. Padlan

Expert Declaration of Edward Ball M.D.

Petition for Inter Partes Review of US Patent No. 6,407,213

Exhibit 1003C - Exhibits A-O of Dr. Eduardo A. Padlan's Declaration